Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

Share Price is delayed by 15 minutes
Get Live Data
886.00    -14.00 (-1.56%)
Bid:
886.00
Ask:
890.00
Spread: 4.00 (0.451%)
Market Cap: £482.08m
JCH Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Clav Share Chart

Directorate Change

22 Jan 2025 15:48

RNS Number : 3399U
JPMorgan Claverhouse IT PLC
22 January 2025
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

 JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

 

 

APPOINTMENT OF DIRECTOR

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with the UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1)

 

The Board of JPMorgan Claverhouse Investment Trust plc (the 'Company') is pleased to announce the appointment of Mr. Tom Smethers as a Non-Executive Director of the Company with effect from 3rd February 2025.

 

Mr. Smethers is an experienced finance professional, with a strong background in the FMCG, retail, hospitality and aviation sectors. Mr. Smethers has led major transformation projects, handled multiple M&A processes, and has international experience across Europe, the Middle East, and Australia.

Mr. Smethers was previously a Non-Executive Director and Audit Committee Chair of Artemis Alpha Trust plc and is currently a trustee of the charity, Wings for Warriors. He is presently the Chief Financial Officer at Carlsberg Britvic plc and held senior positions at Costa Coffee, TUI Group, Jumeirah Group LLC, and easyJet plc.

 

Mr. Smethers is a Fellow of the Institute of Chartered Accountants of England and Wales.

 

Mr. Smethers does not own any shares of the Company.

 

The Company discloses this information pursuant to the Financial Conduct Authority's UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1). No further information is to be disclosed pursuant to UK Listing Rules 6.4.8 R (2) to 6.4.8 R (6) in respect of Mr. Smethers.

 

 

22nd January 2025

 

 

For further information, please contact:

Anmol Dhillon

JPMorgan Funds Limited, Company Secretary

0800 20 40 20 (or +44 1268 44 44 70)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABUGDBRSDDGUD
Date   Source Headline
16th Apr 20267:00 amRNS-RKepler Trust Intelligence: New Research
15th Apr 202611:21 amRNSNet Asset Value(s)
14th Apr 20263:17 pmRNSTen Largest Investments
14th Apr 202610:54 amRNSNet Asset Value(s)
13th Apr 202612:07 pmRNSGearing announcement
13th Apr 202611:12 amRNSNet Asset Value(s)
10th Apr 202611:07 amRNSNet Asset Value(s)
9th Apr 202611:06 amRNSNet Asset Value(s)
8th Apr 202610:27 amRNSNet Asset Value(s)
7th Apr 20265:35 pmRNSNOTIFICATION OF CROSS HOLDING
7th Apr 202612:24 pmRNSGearing Announcement
7th Apr 202611:38 amRNSNet Asset Value(s)
2nd Apr 202611:19 amRNSNet Asset Value(s)
1st Apr 202611:48 amRNSNet Asset Value(s)
1st Apr 202610:10 amRNSTotal Voting Rights
31st Mar 20264:52 pmRNSTransaction in Own Shares
31st Mar 202611:22 amRNSNet Asset Value(s)
30th Mar 20265:14 pmRNSTransaction in Own Shares
30th Mar 202612:06 pmRNSGearing Announcement
30th Mar 202611:30 amRNSNet Asset Value(s)
27th Mar 202611:26 amRNSNet Asset Value(s)
26th Mar 202611:17 amRNSNet Asset Value(s)
25th Mar 202610:56 amRNSNet Asset Value(s)
25th Mar 20267:00 amRNSDirectorate change
25th Mar 20267:00 amRNSDividend Declaration
25th Mar 20267:00 amRNSFinal Results
24th Mar 202611:29 amRNSNet Asset Value(s)
23rd Mar 20261:38 pmRNSGearing Announcement
23rd Mar 202610:58 amRNSNet Asset Value(s)
20th Mar 202611:28 amRNSNet Asset Value(s)
19th Mar 202610:46 amRNSNet Asset Value(s)
18th Mar 202611:02 amRNSNet Asset Value(s)
17th Mar 202611:12 amRNSNet Asset Value(s)
16th Mar 202611:34 amRNSGearing Announcement
16th Mar 202611:34 amRNSGearing Announcement
16th Mar 202611:18 amRNSNet Asset Value(s)
13th Mar 20265:14 pmRNSTransaction in Own Shares
13th Mar 202611:27 amRNSNet Asset Value(s)
11th Mar 20264:15 pmRNSTen Largest Investments
11th Mar 20264:15 pmRNSTen Largest Investments
11th Mar 202611:16 amRNSNet Asset Value(s)
9th Mar 20265:09 pmRNSTransaction in Own Shares
9th Mar 202611:13 amRNSGearing announcement
9th Mar 202610:44 amRNSNet Asset Value(s)
6th Mar 202611:32 amRNSNet Asset Value(s)
5th Mar 202610:54 amRNSNet Asset Value(s)
4th Mar 202611:49 amRNSNet Asset Value(s)
3rd Mar 202611:27 amRNSNet Asset Value(s)
2nd Mar 202612:57 pmRNSGearing Announcement
2nd Mar 202611:25 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.